[RGLS] YoY Quarter Result on 31-Mar-2021 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
13-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -354.84%
YoY- -1.28%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 6 6,778 18 -
PBT -8,469 -7,139 -6,718 -6,013 -5,945 -3,260 -16,024 -10.07%
Tax -81 -45 1 -335 -8 56 1 -
NP -8,469 -7,094 -6,719 -6,013 -5,937 -3,260 -16,025 -10.07%
Tax Rate - - - - - - - -
Total Cost 8,469 7,094 6,719 6,013 5,943 10,038 16,043 -10.09%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 -98,950.00 -48.10 -89,027.78 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.29 -0.42 -0.46 -0.84 -2.47 -3.14 -18.49 -49.93%
EPS Diluted -0.29 -0.42 -0.46 -0.84 -2.47 -3.14 -18.49 -49.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.